NeuroOne Medical Technologies (NASDAQ:NMTC) Trading Down 5.8% – Here’s What Happened

NeuroOne Medical Technologies Co. (NASDAQ:NMTC)’s share price dropped 5.8% on Monday . The stock traded as low as $0.94 and last traded at $0.97. Approximately 128,628 shares were traded during trading, a decline of 19% from the average daily volume of 158,317 shares. The stock had previously closed at $1.03.

NeuroOne Medical Technologies Stock Down 5.9 %

The stock has a market cap of $27.16 million, a P/E ratio of -3.38 and a beta of 0.48. The company’s 50 day moving average price is $1.08 and its two-hundred day moving average price is $0.94.

NeuroOne Medical Technologies (NASDAQ:NMTC) last issued its earnings results on Wednesday, February 12th. The company reported $0.06 earnings per share for the quarter. NeuroOne Medical Technologies had a negative return on equity of 270.70% and a negative net margin of 82.17%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new position in shares of NeuroOne Medical Technologies during the third quarter valued at approximately $26,000. Jane Street Group LLC purchased a new stake in NeuroOne Medical Technologies during the fourth quarter worth $33,000. Finally, Geode Capital Management LLC boosted its position in NeuroOne Medical Technologies by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 283,855 shares of the company’s stock valued at $281,000 after acquiring an additional 24,972 shares in the last quarter. Hedge funds and other institutional investors own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.